222 related articles for article (PubMed ID: 24391945)
1. Heterogeneous persister cells formation in Acinetobacter baumannii.
Barth VC; Rodrigues BÁ; Bonatto GD; Gallo SW; Pagnussatti VE; Ferreira CA; de Oliveira SD
PLoS One; 2013; 8(12):e84361. PubMed ID: 24391945
[TBL] [Abstract][Full Text] [Related]
2. Combination of polymyxin B and meropenem eradicates persister cells from Acinetobacter baumannii strains in exponential growth.
Gallo SW; Ferreira CAS; de Oliveira SD
J Med Microbiol; 2017 Aug; 66(8):1257-1260. PubMed ID: 28721845
[No Abstract] [Full Text] [Related]
3. Combination of colistin and tobramycin inhibits persistence of Acinetobacter baumannii by membrane hyperpolarization and down-regulation of efflux pumps.
Kashyap S; Kaur S; Sharma P; Capalash N
Microbes Infect; 2021; 23(4-5):104795. PubMed ID: 33567337
[TBL] [Abstract][Full Text] [Related]
4. Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.
Wong FH; Cai Y; Leck H; Lim TP; Teo JQ; Lee W; Koh TH; Tan TT; Tan KW; Kwa AL
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818819
[TBL] [Abstract][Full Text] [Related]
5. A novel decoy strategy for polymyxin resistance in
Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
Elife; 2021 Jun; 10():. PubMed ID: 34180396
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of persister cells and the diversity of type II toxin - antitoxin system in Acinetobacter baumannii].
Ma Y; Zhu Y; Li W; Liu F; Lv N; Li J; Zhu B; Hu Y
Wei Sheng Wu Xue Bao; 2015 Jul; 55(7):949-58. PubMed ID: 26710614
[TBL] [Abstract][Full Text] [Related]
7. Levels of persisters influenced by aeration in Acinetobacter calcoaceticus-baumannii.
Donamore BK; Gallo SW; Abreu Ferreira PM; Sanchez Ferreira CA; de Oliveira SD
Future Microbiol; 2018 Feb; 13():209-219. PubMed ID: 29302999
[TBL] [Abstract][Full Text] [Related]
8. Non-walled spherical
Zou J; Kou SH; Xie R; VanNieuwenhze MS; Qu J; Peng B; Zheng J
Emerg Microbes Infect; 2020 Dec; 9(1):1149-1159. PubMed ID: 32419626
[TBL] [Abstract][Full Text] [Related]
9. Eradication of persister cells of Acinetobacter baumannii through combination of colistin and amikacin antibiotics.
Chung ES; Ko KS
J Antimicrob Chemother; 2019 May; 74(5):1277-1283. PubMed ID: 30759206
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
[TBL] [Abstract][Full Text] [Related]
11. Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
Walsh CC; Landersdorfer CB; McIntosh MP; Peleg AY; Hirsch EB; Kirkpatrick CM; Bergen PJ
J Antimicrob Chemother; 2016 Aug; 71(8):2218-29. PubMed ID: 27118778
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.
Hagihara M; Housman ST; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2014; 58(2):874-9. PubMed ID: 24277022
[TBL] [Abstract][Full Text] [Related]
13. Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates.
Barin J; Martins AF; Heineck BL; Barth AL; Zavascki AP
Ann Clin Microbiol Antimicrob; 2013 Jul; 12():15. PubMed ID: 23819554
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.
Anderson SE; Sherman EX; Weiss DS; Rather PN
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111627
[TBL] [Abstract][Full Text] [Related]
15. Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway.
Sampson TR; Liu X; Schroeder MR; Kraft CS; Burd EM; Weiss DS
Antimicrob Agents Chemother; 2012 Nov; 56(11):5642-9. PubMed ID: 22908157
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.
Rao GG; Ly NS; Bulitta JB; Soon RL; San Roman MD; Holden PN; Landersdorfer CB; Nation RL; Li J; Forrest A; Tsuji BT
J Antimicrob Chemother; 2016 Nov; 71(11):3148-3156. PubMed ID: 27494922
[TBL] [Abstract][Full Text] [Related]
17. Effects of meropenem exposure in persister cells of Acinetobacter calcoaceticus-baumannii.
Gallo SW; Donamore BK; Pagnussatti VE; Ferreira CA; de Oliveira SD
Future Microbiol; 2017 Feb; 12():131-140. PubMed ID: 28111984
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
Rao GG; Ly NS; Diep J; Forrest A; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2016 Sep; 48(3):331-6. PubMed ID: 27449542
[TBL] [Abstract][Full Text] [Related]
19. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
